Profile data is unavailable for this security.
About the company
Ascendis Health Limited is a South Africa-based health and wellness investment holding company. The Company is primarily engaged in marketing and distributing a portfolio of brands, products, and medical devices. The Company operates through two segments: Consumer Health, and Medical Devices. Its Consumer Health segment is a supplier of vitamins, minerals, and supplements in South Africa, with brands such as Solal, Vitaforce, MenaCal7, Bettaway and Junglevite, and includes Consumer Brands, Chempure, and Compounding Pharmacy. Its Medical Devices segment maintains relationships and holds distribution agreements with multinational original equipment manufacturers, which allow Medical Devices to supply surgical, diagnostic, and medical equipment.
- Revenue in ZAR (TTM)1.47bn
- Net income in ZAR41.57m
- Incorporated2008
- Employees3.20k
- LocationAscendis Health Ltd1 Carey Street, WynbergSANDTON 2090South AfricaZAF
- Phone+27 110369600
- Fax+27 110369602
- Websitehttps://ascendishealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Modern Chinese Medicine Group Co Ltd | 587.85m | 35.09m | 417.12m | 190.00 | 11.89 | 0.3659 | 8.27 | 0.7096 | 0.0265 | 0.0265 | 0.4439 | 0.8609 | 0.482 | 5.62 | 4.24 | 1,394,572.00 | 2.88 | 20.76 | 3.08 | 25.82 | 27.70 | 41.02 | 5.97 | 20.11 | 10.90 | -- | 0.001 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
| Kontafarma China Holdings Ltd | 1.85bn | -139.56m | 419.35m | 717.00 | -- | 0.1786 | 18.53 | 0.227 | -0.0113 | -0.0113 | 0.150 | 0.1904 | 0.4756 | 3.52 | 6.67 | 1,162,388.00 | -4.95 | -1.33 | -6.40 | -2.18 | 59.88 | 54.70 | -10.40 | -4.12 | 1.24 | -6.56 | 0.2116 | -- | -9.50 | -17.32 | 66.02 | -- | -19.55 | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 3.85m | -167.63m | 427.99m | 12.00 | -- | 1.78 | -- | 111.28 | -25.21 | -25.21 | 0.5784 | 36.04 | 0.0106 | 0.2228 | -- | 2,703,333.00 | -46.21 | -36.51 | -50.76 | -39.47 | 76.16 | -- | -4,358.35 | -13,528.87 | 8.51 | -- | 0.0604 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| KALA BIO Inc | 0.00 | -664.71m | 431.91m | 43.00 | -- | 1.83 | -- | -- | -13.95 | -13.95 | 0.00 | 2.98 | 0.00 | -- | -- | 0.00 | -60.45 | -57.83 | -78.16 | -69.32 | -- | 57.06 | -- | -1,553.61 | -- | -11.36 | 0.7174 | -- | -100.00 | -- | 5.85 | -- | -17.31 | -- |
| Bioalpha Holdings Bhd | 245.51m | -149.71m | 436.92m | -- | -- | 0.8024 | -- | 1.78 | -0.0336 | -0.0336 | 0.0464 | 0.0935 | 0.3261 | 7.56 | 8.57 | -- | -21.03 | -13.18 | -25.34 | -14.20 | 2.66 | 8.08 | -64.50 | -45.88 | 2.05 | -64.81 | 0.0733 | -- | 28.75 | -8.04 | 12.19 | -- | -33.09 | -- |
| Polypid Ltd | 0.00 | -424.09m | 437.08m | 59.00 | -- | 10.85 | -- | -- | -9.65 | -9.65 | 0.00 | 0.3337 | 0.00 | -- | -- | 0.00 | -107.89 | -76.92 | -164.39 | -89.61 | -- | -- | -- | -- | -- | -24.21 | 0.8425 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
| Indofarma Tbk PT | 304.93m | -795.40m | 442.09m | 900.00 | -- | -- | -- | 1.45 | -226.69 | -226.69 | 86.91 | -292.35 | 0.2263 | 2.69 | 1.99 | 248,022,500.00 | -59.03 | -15.78 | -- | -37.17 | -62.99 | 12.54 | -260.85 | -16.15 | 0.142 | -9.03 | -- | -- | -46.59 | -19.95 | -57.55 | -- | -36.74 | -- |
| Ascendis Health Ltd | 1.47bn | 41.57m | 442.73m | 3.20k | 10.74 | 0.7176 | 4.49 | 0.3008 | 0.0652 | 0.09 | 2.34 | 0.9755 | 1.45 | 2.33 | 4.98 | -- | 4.09 | -13.31 | 6.68 | -33.27 | 39.75 | 39.17 | 2.82 | -49.09 | 0.9089 | 12.91 | 0.0739 | -- | -4.13 | -24.17 | 114.52 | -- | -36.02 | -- |
| Liberta Co Ltd | 935.64m | -2.42m | 449.66m | 118.00 | -- | 2.46 | 26.86 | 0.4806 | -3.49 | -3.49 | 1,325.93 | 256.06 | 1.21 | 2.88 | 5.72 | 66,877,950.00 | -0.3155 | 3.75 | -0.6765 | 6.42 | 37.15 | 41.81 | -0.2615 | 2.37 | 0.8419 | -- | 0.7196 | 35.67 | 6.77 | 9.76 | -2.77 | -12.85 | 23.12 | -- |
Data as of Sep 26 2024. Currency figures normalised to Ascendis Health Ltd's reporting currency: South African Rand ZAR
0.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Excelsia Capital Pty Ltd.as of 30 Jun 2024 | 268.91k | 0.04% |
| SSgA Funds Management, Inc.as of 05 Sep 2024 | 3.15k | 0.00% |
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
